Approval · Notice of Compliance 1027 · 2000
PLAVIX: Notice of Compliance 1027
Issued November 28, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1027
- Date
- November 28, 2000
- Company
- Sanofi-Synthelabo Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Platelet aggregation inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLAVIX | 02238682 | Marketed |
Medicinal ingredients
- CLOPIDOGREL BISULFATE 75 MG per TAB